Osmetech Plc: Warfarin Test Submitted For FDA Approval

LONDON--(BUSINESS WIRE)--Osmetech plc ('Osmetech' or the 'Company') (LSE:OMH), the fast developing international molecular diagnostics business announces that it has submitted its eSensorĀ® 2C9/VKOR test to the US Food and Drug Administration (FDA) for 510(k) pre-marketing clearance. The test is to be used as an aid in the identification of patients at risk for increased sensitivity for the widely used blood-thinning drug, warfarin.

Back to news